Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 19.05% is 11% above its 5-year average of 17.10%, near the high end of its 5-year range (12.60%–19.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.32% below its 12-month average of 19.30%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
19.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
19.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
17.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
17.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
15.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
13.55%
CURRENT VS TTM AVG
-1.32%
CURRENT VS 3Y AVG
+6.29%
CURRENT VS 5Y AVG
+11.43%
CURRENT VS 10Y AVG
+24.64%
CURRENT VS 15Y AVG
+27.93%
CURRENT VS 20Y AVG
+40.62%
SECTOR MEDIAN · HEALTHCARE
8.81%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+116.23%
vs the sector median at left
ResMed Inc.
Market Cap
$31.76B
Return on Invested Capital (ROIC)
19.05%
TTM Avg
19.30%
3Y Avg
17.92%
5Y Avg
17.10%
Market Cap
$30.96B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$30.68B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$30.68B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$32.81B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$33.03B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
Market Cap
$33.20B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$29.12B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$29.19B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.77%
3Y Avg
-7.01%
5Y Avg
-13.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $31.76B | 19.05% | 19.30% | 17.92% | 17.10% |
| Zoetis Inc. (ZTS)vs › | $30.96B | 21.54% | 21.87% | 20.30% | 19.27% |
| Waters Corporation (WAT)vs › | $30.68B | 17.57% | 18.00% | 20.73% | 22.79% |
| Biogen Inc. (BIIB)vs › | $30.68B | 6.62% | 7.71% | 8.64% | 10.90% |
| Centene Corp. (CNC)vs › | $32.81B | -13.41% | -4.17% | -0.53% | 0.76% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $33.03B | 8.84% | 8.56% | 8.37% | 9.38% |
| DexCom, Inc. (DXCM)vs › | $33.20B | 16.61% | 13.40% | 11.07% | 9.62% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.12B | 35.46% | 38.26% | 37.51% | 36.01% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.19B | 13.74% | 4.77% | -7.01% | -13.46% |
| Medline Inc. (MDLN)vs › | $28.60B | 5.69% | 6.03% | 3.95% | 3.95% |
ROIC
19.1%
ROE
23.1%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 19.05% |
| 2025-06-30 | 19.56% |
| 2024-06-30 | 17.77% |
| 2023-06-30 | 15.31% |
| 2022-06-30 | 18.29% |
| 2021-06-30 | 12.60% |
| 2020-06-30 | 17.09% |
| 2019-06-30 | 12.68% |
| 2018-06-30 | 12.79% |
| 2017-06-30 | 11.20% |
| 2016-06-30 | 11.78% |
| 2015-06-30 | 17.30% |
| 2014-06-30 | 15.51% |
| 2013-06-30 | 14.61% |
| 2012-06-30 | 11.99% |
| 2011-06-30 | 10.72% |
| 2010-06-30 | 12.22% |
| 2009-06-30 | 10.58% |
| 2008-06-30 | 7.95% |
| 2007-06-30 | 5.66% |
| 2006-06-30 | 9.83% |
| 2005-06-30 | 9.73% |
| 2004-06-30 | 11.82% |
| 2003-06-30 | 11.20% |
| 2002-06-30 | -10.74% |
| 2001-06-30 | 4.36% |
| 2000-06-30 | 22.94% |
| 1999-06-30 | 23.09% |
| 1998-06-30 | 22.33% |
| 1997-06-30 | 12.41% |
